Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
Date
2011-05-05
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regarding long bone insufficiency fractures related to long-term alendronate therapy. We report a case of bilateral femoral insufficiency fractures likely related to long-term alendronate therapy, the classic symptoms, signs, and treatment of these fractures.
Description
Keywords
Citation
Ravindra Gudena, Jason Werle, and Kelly Johnston, “Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy,” Journal of Osteoporosis, vol. 2011, Article ID 810697, 4 pages, 2011. doi:10.4061/2011/810697